Why Biotech Companies Need a Go-to-Market Strategy Before Series B

Most biotech companies wait until Phase III or later to think about commercial strategy. By then, critical decisions have already been made — often badly. Here is why GTM planning should start earlier.

How to Launch a Medical Device in the UK: A Step-by-Step Guide

Launching a medical device in the UK requires navigating regulatory approval, market access, and commercial strategy simultaneously. Here is a practical guide to getting it right.